News | April 13, 2009

April 14, 2009 - Abstract submissions are due on May 11, 2009, for the World Molecular Imaging Congress (WMIC 2009), which will be held from Sep. 23-26 in Montreal.

The current rate of submission suggests that WMIC 2009 will receive more abstracts than for WMIC 2008. The group is using a new submission system, Abstract Central, a ScholarOne product.

Abstract Central is configured to collect disclosures of financial relationships directly from each co-author. Every co-author will receive an email urging them to access the system and complete their disclosures. All co-authors are required complete their disclosures in order for an abstract to be accepted for presentation.

Abstract Central is designed to enable affiliation consistency and accuracy by requiring the submitting author to create affiliations first and then to add authors, selecting the proper affiliation for each author.

WMIC 2009 has arranged for Abstract Central to create an account for each submitting author who participated in previous WMIC, JMIC or SMI.
WMIC 2009 will embrace all aspects of molecular imaging, and, except for the first day's Educational Sessions, the program will be constructed almost entirely on the strength of submitted abstracts.

For more information: http://wmicmeeting.org/dev/


Additional Content

News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
News | PET Imaging

March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...

Time April 06, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
Subscribe Now